BackRayzeBio Overview

RayzeBio Total Current Liabilities

Latest total current liabilities for RYZB: $17M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$17.11M

Peer average

Loading

RayzeBio Total Current Liabilities History

Loading

RayzeBio vs. peers: Total Current Liabilities Comparison

Loading

RayzeBio Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

RayzeBio (RYZB) FAQ

RayzeBio's total current liabilities stands at $17M as of September 2023. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether RayzeBio's total current liabilities is expanding or contracting. Sustained growth in total current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how RayzeBio's total current liabilities evolved across reporting periods, while the comparison chart places RYZB next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.